BioUtah today applauded the four winning life sciences companies of its Pitch Competition held March 12 during the 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the Brigham Young University (BYU) Technology Transfer Office and College of Life Sciences. The winners were chosen from categories including therapeutics and pharmaceuticals, medical devices/diagnostics, and digital health and biotechnology.
Azunic AI, Purgo Scientific, Freyya, and Intactis Bio each received a $4,000 cash prize, marketing consulting services, and a one-year membership in BioUtah. The competition, now in its sixth year, provides early-stage companies with exposure to investors and industry leaders, a critical opportunity in a sector where funding and mentorship can determine success.
The implications of these awards extend beyond the immediate prizes. For the winners, validation from a respected industry association can attract further investment and partnerships. BioUtah, as a trade association serving Utah’s life sciences industry, underscores the state’s growing role as a hub for biomedical innovation. With member companies spanning medical device manufacturing, biotechnology, and diagnostics, the organization’s support signals that these startups align with strategic priorities in healthcare advancement.
Azunic AI, operating in digital health, leverages artificial intelligence to improve patient outcomes, a sector that has seen exponential growth and investor interest. Purgo Scientific, in the medical device category, focuses on novel solutions for clinical challenges. Freyya, in therapeutics, and Intactis Bio, in biotech, address unmet needs in drug development and biological research. Each company’s success in the pitch competition suggests their technologies have commercial viability and scientific merit.
The summit, co-presented with BYU’s Technology Transfer Office and College of Life Sciences, highlights the synergy between academic research and industry application. BYU’s involvement facilitates the transfer of innovative ideas from the lab to the market, a process critical for translating discoveries into real-world treatments. The cash prize and consulting services provide tangible support, but the networking opportunities and exposure to potential partners may prove more valuable long-term.
For Utah’s economy, these startups represent job creation and diversification. The life sciences sector is a key driver, and nurturing early-stage companies helps maintain a pipeline of innovation. The E&I Summit, now in its 12th year, has become a staple event for entrepreneurs and investors, and the pitch competition is a highlight that showcases emerging talent.
While the winners were selected from a competitive field, all participants gain visibility. The event’s structure encourages collaboration and knowledge sharing, essential for an industry where breakthroughs often require interdisciplinary approaches. As these companies move forward, the support from BioUtah and partners like Wilson Sonsini and BYU will be instrumental in their growth trajectories.
